Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Levetiracetam (1500mg) Infusion
Dosage Form : Infusion
Packaging Type :
Packaging :
Price : ₹1/-
Lapcetam RTU 1500 Infusion is a ready-to-use intravenous formulation containing Levetiracetam (1500 mg), specifically designed for the rapid management of epilepsy in critical settings. This antiepileptic medication is primarily utilized when oral administration is not feasible, such as during acute seizures or when patients are unconscious or unable to swallow.
Levetiracetam acts by modulating synaptic vesicle protein 2A, which helps stabilize neuronal activity and suppress abnormal electrical discharges in the brain. Its intravenous route ensures quick onset of action, making it ideal for status epilepticus, sudden exacerbations of seizures, or transitioning patients from oral antiepileptic medications during surgery or hospitalization.
Lapcetam RTU 1500 Infusion is premixed and ready for immediate administration, reducing preparation time and ensuring accuracy in dosage. Its well-tolerated profile and minimal drug-drug interactions make it a reliable choice in emergency care or intensive care units. This formulation can also be seamlessly integrated into a patient's long-term epilepsy management plan when oral medications are resumed.
Common side effects may include drowsiness, dizziness, fatigue, and irritability. Rare adverse effects may include mood changes, allergic reactions, or injection site discomfort.
Lapcetam RTU 1500 Infusion is indicated for the management of status epilepticus and other acute seizure conditions when oral administration of Levetiracetam is not possible.
This medication should only be administered under medical supervision in a healthcare facility. Avoid abrupt discontinuation to prevent rebound seizures. Report any adverse effects or unusual symptoms to the healthcare provider promptly.
Composition : Levetiracetam (1000mg) Infusion
Composition : Levetiracetam (500mg) Infusion
Composition : Levofloxacin 500mg Infusion
Composition : Linezolid Intravenous Infusion I.P. 2mg Infusion
Composition : Levetiracetam (100mg/ml)
Composition : Pregabalin (300mg)
Composition : Pregabalin (150mg)
Composition : Levetiracetam (250mg)
Composition : Levetiracetam (500mg)
Composition : Levetiracetam (750mg)